Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Tian-Kang Guo
Xiang-Yong Hao
Bin Ma
Ke-Hu Yang
Yi-Ping Li
Hong-Ling Li
Yuan-Hui Gu
Hui Cai
Ya-Li Liu
Yuan Li
Wei-Peng Zhan
机构：
[1] The People’s Hospital of Gansu Province,
[2] Evidence-Based Medicine Center of Lanzhou University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2009年 / 135卷
关键词：
Hepatocellular carcinoma; Octreotide; Liver disease; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1685 / 1692
页数：7
相关论文
共 50 条
  • [1] Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Guo, Tian-Kang
    Hao, Xiang-Yong
    Ma, Bin
    Yang, Ke-Hu
    Li, Yi-Ping
    Li, Hong-Ling
    Gu, Yuan-Hui
    Cai, Hui
    Liu, Ya-Li
    Li, Yuan
    Zhan, Wei-Peng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (12) : 1685 - 1692
  • [2] Somatostatin analogues in advanced hepatocellular carcinoma: An updated systematic review and meta-analysis of randomized controlled trials
    Ji, Xi-Qing
    Ruan, Xin-Jian
    Chen, Hong
    Chen, Gang
    Li, Shi-Yong
    Yu, Bo
    MEDICAL SCIENCE MONITOR, 2011, 17 (08): : RA169 - RA176
  • [3] Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
    Han, Yue
    Zhi, Wei-Hua
    Xu, Fei
    Zhang, Chen-Bo
    Huang, Xiao-Qian
    Luo, Jian-Feng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (19) : 2415 - 2433
  • [4] Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials
    Shao, Yu-Yun
    Shau, Wen-Yi
    Chan, Soa-Yu
    Lu, Li-Chun
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    ONCOLOGY, 2015, 88 (06) : 345 - 352
  • [5] Chemotherapy for advanced biliary tract carcinoma A meta-analysis of randomized controlled trials
    Chen, Lawrence
    Chen, Chiehfeng
    Yen, Yun
    Tam, Ka-Wai
    MEDICINE, 2016, 95 (33)
  • [6] Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials
    Zhang, Tao
    Ding, Xin
    Wei, Dong
    Cheng, Peng
    Su, Xiaomei
    Liu, Huanyi
    Wang, Daoyuan
    Gao, Hui
    ANTI-CANCER DRUGS, 2010, 21 (03) : 326 - 332
  • [7] Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Biao Yang
    Rui-yu Zan
    Shi-yu Wang
    Xiang-lian Li
    Mao-ling Wei
    Wen-hao Guo
    Xin You
    Jing Li
    Zheng-yin Liao
    World Journal of Surgical Oncology, 13
  • [8] Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Yang, Biao
    Zan, Rui-yu
    Wang, Shi-yu
    Li, Xiang-lian
    Wei, Mao-ling
    Guo, Wen-hao
    You, Xin
    Li, Jing
    Liao, Zheng-yin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [9] Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Yu, Qian
    Liu, Chenyu
    Navuluri, Rakesh
    Ahmed, Osman
    ABDOMINAL RADIOLOGY, 2021, 46 (09) : 4467 - 4475
  • [10] Transarterial Chemoembolization Combined with Lenvatinib for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Pei, Xiaxia
    Zhao, Jun
    Wang, Zhiping
    ONCOLOGY, 2024, 102 (08) : 688 - 702
12345